Variations in proteasome subunit composition and enzymatic activity in B-lymphoma lines and normal B cells

International Journal of Cancer

Volumn 88, Issue 6, 2000, Pages 881-888

  Frisan, Teresa ^a   Levitsky, Victor ^a   Masucci, Maria G ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; LIPOPOLYSACCHARIDE; PROTEASOME;

ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; BURKITT LYMPHOMA; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; ENZYME SUBUNIT; HODGKIN DISEASE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHOBLASTOID CELL LINE; PRIORITY JOURNAL;

B-LYMPHOCYTES; CHYMOTRYPSIN; CYSTEINE ENDOPEPTIDASES; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOMA, B-CELL; MULTIENZYME COMPLEXES; MUSCLE PROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEINS; TRYPSIN; TUMOR CELLS, CULTURED;

EID: 0034672376     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20001215)88:6<881::AID-IJC7>3.0.CO;2-D     Document Type: Article

References (46)

1. Interferon-γ induces different subunit organizations and functional diversity of proteasomes
2. The pathology of Hodgkin's disease
3. The proteasome: Paradigm of a self-compartmentalizing protease
4. Differential presentation of the same MHC class I epitopes by fibroblasts and dendritic cells
5. The nature of the B lymphocyte in B-chronic lymphocytic leukemia
6. Catalytic components of the bovine pituitary multicatalytic proteinase complex (proteasome)
7. Altered properties of the branched chain amino acid-preferring activity contribute to increased cleavages after branched chain residues by the 'immunoproteasome'
8. T cell responses and virus evolution: Loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from highly A11-positive populations by selective mutation of anchor residues
9. Activation of latent EBV via anti-IgG-triggered, second messenger pathways in the Burkitt's lymphoma cell line Akata
10. MHC-linked LMP gene products specifically alter peptidase activities of the proteasome
11. Bovine spleen multicatalytic proteinase complex (proteasome)
12. MHC class I expression in mice lacking the proteasome subunit LMP-7
13. Phenotype-dependent differences in proteasome subunit composition and cleavage specificity in B cell lines
14. γ-Interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes
15. The major histocompatibility complex-encoded proteasome component LMP7: Alternate first exon and post-translational processing
16. Identification of a subset of normal B cells with a Burkitt's lymphoma (BL)-like phenotype
17. Immunoproteasome assembly: Cooperative incorporation of interferon-γ (IFN-γ)-inducible subunits
18. A third interferon-γ-induced subunit exchange in the 20S proteasome
19. Structure of 20S proteasome from yeast at 2.4Å resolution
20. The cellular biology of the Reed-Sternberg cell
21. Simultaneous binding of PA28 and PA700 activators to 20S proteasomes
22. Human proteasomes analysed with monoclonal antibodies
23. Methods of peptide synthesis
24. Newly identified pair of proteasomal subunits regulated reciprocally by interferon-γ
25. Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (cripple) germinal center B cells
26. Assembly and function of the two ABC transporter proteins encoded in the human histocompatibility complex
27. 1-regulating proteins by Epstein-Barr virus mutants conditional for EBNA2
28. Incorporation of major histocompatibility complex-encoded subunits LMP2 and LMP7 changes the quality of the 20S proteasome polypeptide processing products independent of interferon-γ
29. The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4
30. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: In vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells
31. Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell
32. c-myc activation renders proliferation of Epstein-Barr virus (EBV)-transformed cells independent of EBV nuclear antigen 2 and latent membrane protein 1
33. Degradation of cell proteins and the generation of MHC class I-presented peptides
34. Endemic Burkitt's lymphoma: Phenotypic analysis of tumour biopsy cells and of the derived tumour cell lines
35. Monoclonal antibodies to Epstein-Barr virus-induced, transformation-associated cell surface antigens: Binding patterns and effect upon virus-specific T-cell cytotoxicity
36. Proteasome from Thermoplasma acidophylum: A threonine protease
37. 20S proteasome from LMP7 knock out mice reveals altered proteolyric activities and cleavage site preferences
38. Differentiation dependent sensitivity of human B-cell derived lines to major histocompatibility complex-restricted T-cell cytotoxicity
39. Human lymphoblast and erythrocyte multicatalytic proteases: Differential peptidase activities and responses to the 11S regulator
40. Modulation of proteasomal activity required for the generation of a cytotoxic T lymphocyte-defined peptide derived from the tumor antigen MAGE-3
41. Altered peptidase and viral-specific T cell response in LMP2 mutant mice
42. Peripheral blood mononuclear cells of a patient with advance Hodgkin's lymphoma give rise to permanently growing Hodgkin-Reed Sternberg cells
43. MHC-encoded proteasome subunits LMP2 and LMP7 are not required for efficient antigen presentation
44. b or K(d) in proteasome subunit LMP2- and LMP7-deficient cells